STAT3 and cancer: MDSCs in TME released IL-6 to constantly activate STAT3 in cancer cells, which conferred invasive potential to cancer cells [32], induced epithelial mesenchymal transition (EMT) of cancer cells [33], and enhanced cancer cell stemness [34].